Natural Killer Cells May Offer a Better Cancer Treatment Than CAR-T
More than a century ago, William Coley, a surgical oncologist from New York City, had the seemingly crazy notion that the body has an immune system that can be harnessed to fight cancer.
Virus-free CRISPR could mean faster, more precise gene editing for T-cell therapies
A team from the University of California, San Francisco, devised a new electroporation-based CRISPR-Cas9 method, eliminating viruses from the gene editing process and laying the groundwork for safer, more precise and more efficient editing for CAR-T cancer treatments and other cell therapies.
Stem cell mutations linked to hydrocephalus
Hydrocephalus is characterized by a dangerous buildup of pressure on the brain caused by excessive amounts of fluid.
Scientists Find and Repair Flaw in CRISPR Gene-Editing
To date, CRISPR gene-editing remains to be one of the most promising medical treatments currently being studied by researchers worldwide.
CELLforCURE will produce innovative cancer CAR-T treatments for Novartis
Novartis announced today that it had signed an agreement with CELLforCURE to produce innovative cancer treatments known as CAR-T therapies (“chimeric antigen receptor T-cells”) at the bioproduction site based in Les Ulis (Essonne).
Type 2 diabetes, obesity may soon be reversed with gene therapy
The prevalence of diabetes, or the total number of existing cases, is on the rise in the United States and globally.
Smart bandages designed to monitor and tailor treatment for chronic wounds
A team of engineers led by Tufts University has developed a prototype bandage designed to actively monitor the condition of chronic wounds and deliver appropriate drug treatments to improve the chances of healing.
The 3rd National Festival and International Congress on Stem Cells and Regenerative Medicine
Considerable advances in Stem Cells and Regenerative Medicine during the past decade, has created much hope for the treatment of chronic and incurable illnesses, such as various cancers, genetic illnesses, illnesses due to old age, and deterioration of tissues and organs.
Stem cell study brings scientists closer to understanding schistosomiasis
Schistosomiasis currently affects more than 250 million people, mainly in Asia and Africa, and the WHO has estimated that it causes approximately 280,000 deaths per year.
Stem Cells Shows Promise For Repairing Torn Meniscus
U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced it has demonstrated successful, in-human results in repairing meniscus tear after autologous stem cell therapy from adipose or fat tissue.
